Ross, LL; Walker, AS; Lou, Y; Tenorio, AR; Gibb, DM; Double, J; Gilks, C; ... Shaefer, MS; + view all Ross, LL; Walker, AS; Lou, Y; Tenorio, AR; Gibb, DM; Double, J; Gilks, C; McCoig, CC; Munderi, P; Musoro, G; Kityo, CM; Grosskurth, H; Hakim, J; Mugyenyi, PN; Cutrell, A; Perger, T; Shaefer, MS; - view fewer (2019) Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30–49 vs ≥50 mL/min. PLoS One , 14 (11) , Article e0225199. 10.1371/journal.pone.0225199.